HiberCell to Present Posters on Novel Candidates Odetiglucan and HC-7366 at the 2022 Annual American Society of Clinical Oncology Meeting
Overviews of the clinical trials to be presented in the trials-in-progress poster sessionsNEW YORK, May 24, 2022 (GLOBE NEWSWIRE) --...
Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01